Skip Nav Destination
Issues
Research Articles
A Comparison of Single and Combined Visual, Cytologic, and Virologic Tests as Screening Strategies in a Region at High Risk of Cervical Cancer1
Catterina Ferreccio; Maria C. Bratti; Mark E. Sherman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Robert D. Burk; Martha Hutchinson; Mario Alfaro; Mitchell D. Greenberg; Jorge Morales; Ana C. Rodriguez; John Schussler; Claire Eklund; Guillermo Marshall; Mark Schiffman
Short Communications
Null Results in Brief
No Association between Haplotypes of Three Variants (Codon 81, 284, and 762) in Poly(ADP-ribose) Polymerase Gene and Risk of Primary Lung Cancer1
Jin Eun Choi; Sun Ha Park; Hyo-Sung Jeon; Kyung Mee Kim; Ga Young Lee; Rang Woon Park; Sin Kam; In-San Kim; Chang Ho Kim; Sang Hoon Jheon; Tae Hoon Jung; Jae Yong Park
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.